证券代码：300869 证券简称：康泰医学 公告编号：2025-045 债券代码：123151 债券简称：康医转债 康泰医学系统（秦皇岛）股份有限公司 关于"康医转债"转股价格调整的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 一、可转换公司债券基本情况 经中国证券监督管理委员会《关于同意康泰医学系统（秦皇岛）股份有限公 司向不特定对象发行可转换公司债券注册的批复》（证监许可〔2022〕960 号）同 意注册，康泰医学系统（秦皇岛）股份有限公司（以下简称"公司"或"康泰医 学"）向不特定对象发行 7,000,000 张可转换公司债券，每张面值为 100 元，募集 资金总额人民币 700,000,000.00 元。经深圳证券交易所（以下简称"深交所"）同 意，公司本次可转换公司债券于 2022 年 7 月 20 日起在深交所挂牌交易，债券简 称"康医转债"，债券代码"123151"，初始转股价格为 28.22 元/股。 二、"康医转债"转股价格调整的相关规定 《康泰医学系统（秦皇岛）股份有限公司创业板向不特定对象发行可转换公 司债券募集说明书 ...

Group 1 - Zhejiang Yitian Intelligent Kitchen Appliances Co., Ltd. announced the suspension of conversion for its convertible bonds "Yitian Convertible Bonds" during the implementation of the 2024 annual equity distribution from May 26, 2025, until the equity registration date [1] - The company held its 2024 annual general meeting on May 15, 2025, where the proposal for profit distribution and capital reserve transfer to share capital was approved [1] - The convertible bonds will continue to trade normally during the suspension period, and bondholders are advised to pay attention [1] Group 2 - The adjustment of the conversion price will occur in the event of stock dividends, capital increases, new share issuances, cash dividends, etc., using specific formulas for calculation [2] - The formulas for adjusting the conversion price include variables such as the number of shares issued, cash dividends, and the previous conversion price [2] - The company will disclose the adjustment details and the suspension period in accordance with relevant laws and regulations [2] Group 3 - In cases of share buybacks, mergers, splits, or any other events affecting the company's share categories or shareholder equity, the company will adjust the conversion price to protect the rights of convertible bondholders [3] - The adjustment will be based on fairness and will comply with national laws and regulations [3]

Group 1 - The company announced the completion of the registration of restricted stock ownership, leading to an adjustment in the convertible bond conversion price [1] - The previous conversion price was set at 23.25 CNY per share, which has been adjusted to 23.19 CNY per share [1] - The adjustment will take effect on May 27, 2025, with the conversion of the convertible bond suspended on May 26, 2025 [1] Group 2 - The company completed the registration of 4,500,659 shares at a price of 8.69 CNY per share as part of its 2023 restricted stock incentive plan [1] - Following this registration, the total share capital increased from 1,127,568,192 shares to 1,132,068,851 shares [1] - The adjustment of the conversion price is in accordance with the terms outlined in the company's prospectus for the convertible bonds [1]

债券代码：123124 债券简称：晶瑞转 2 晶瑞电子材料股份有限公司 关于"晶瑞转债"、 "晶瑞转 2"暂停转股的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 债券代码：123124 债券简称：晶瑞转2 证券代码：300655 证券简称：晶瑞电材 公告编号：2025-059 债券代码：123031 债券简称：晶瑞转债 "晶瑞转2"的转股期限：2022年2月21日至2027年8月15日 "晶瑞转债"、 "晶瑞转2"计划暂停转股时间：2025年5月23日至2024年年 度权益分派股权登记日止 登记日后的第一个交易日 晶瑞电子材料股份有限公司（原名苏州晶瑞化学股份有限公司，以下简称"公 司" ）将于近日发布2024年年度权益分派实施公告，根据《苏州晶瑞化学股份有 限公司创业板公开发行可转换公司债券募集说明书》、 《晶瑞电子材料股份有限公 司创业板向不特定对象发行可转换公司债券募集说明书》中"转股价格的调整方 式及计算公式"的条款规定（详见附件）及有关业务办理指南的规定，自2025年 券代码：123031）和"晶瑞转2"（债券代码：1231 ...

证券代码：002614 股票简称：奥佳华 公告编号：2025-22 号 债券代码：128097 债券简称：奥佳转债 奥佳华智能健康科技集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 一、关于可转换公司债券转股价格调整的相关规定 奥佳华智能健康科技集团股份有限公司（以下简称"公司"或"本公司"） 公开发行了 1,200 万张可转换公司债券（债券简称：奥佳转债，债券代码：128097） 并于 2020 年 3 月 18 日上市。根据《公司公开发行可转换公司债券募集说明书》 及中国证券监督管理委员会（以下简称"中国证监会"）关于可转换公司债券发 行的有关规定，在本次可转换公司债券发行之后，当公司因派送股票股利、转增 股本、增发新股（不包括因本次可转换公司债券转股而增加的股本）、配股使公 司股份发生变化及派送现金股利等情况时，将按下述公式进行转股价格的调整 增发新股或配股：P1=（P0+A×k）/（1+k） 上述两项同时进行：P1=（P0+A×k）/（1+n+k） 派送现金股利：P1=P0－D 上述三项同时进行：P1＝（P0－D+A×k） ...

证券代码：300224 证券简称：正海磁材 公告编号：2025-18-04 债券代码：123169 债券简称：正海转债 烟台正海磁性材料股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 一、可转换公司债券基本情况 经中国证券监督管理委员会《关于同意烟台正海磁性材料股份有限公司向不 特定对象发行可转换公司债券注册的批复》（证监许可〔2022〕2654 号）核准， 烟台正海磁性材料股份有限公司（以下简称"公司"）于 2022 年 11 月 23 日向不 特定对象发行了 1,400.00 万张可转换公司债券（以下简称"正海转债"），每张 面值 100 元，发行总额 140,000.00 万元。公司本次发行的可转债转股期限自可 转债发行结束之日起满六个月后的第一个交易日起至可转债到期日止，即 2023 年 5 月 29 日至 2028 年 11 月 22 日止。 正海转债的初始转股价格为 13.23 元/股。 因公司实施 2022 年年度权益分派方案，"正海转债"的转股价格自 2023 年 因公司实施 2023 年年度权益分派方案，"正海转债" ...

Core Points - The company has announced its profit distribution plan for the fiscal year 2024, which includes a cash dividend of RMB 1.00 for every 10 shares held, with no bonus shares or capital reserve conversion [1][2] - The total share capital of the company is 623,476,857 shares, and the cash dividend will be distributed based on this figure [2][3] - The record date for the distribution is set for May 28, 2025, and the ex-dividend date is May 29, 2025 [3] Profit Distribution Plan - The profit distribution plan specifies that shareholders will receive RMB 1.00 per 10 shares, with different tax treatments for various types of shareholders [2][3] - For Hong Kong market investors and certain foreign institutions, the cash dividend will be RMB 0.90 per 10 shares due to tax considerations [2] - The company will not withhold individual income tax at the time of distribution; instead, it will be calculated based on the holding period when shares are sold [3] Convertible Bond Adjustments - The company's convertible bonds, known as "Aojia Convertible Bonds," will have their conversion price adjusted from RMB 9.45 to RMB 9.35 per share following the profit distribution [3][4] - This adjustment will take effect on May 29, 2025, after the completion of the profit distribution [3]

Core Viewpoint - The company has adjusted the conversion price of its convertible bonds, "Weicet Convertible Bonds," from 82.15 yuan per share to 82.00 yuan per share, effective from May 28, 2025, due to the completion of the first vesting period of its 2024 restricted stock incentive plan [1][5]. Group 1: Conversion Price Adjustment - The adjustment of the conversion price is based on the issuance of 325,018 shares to 63 incentive recipients, increasing the total share capital from 113,834,777 shares to 114,159,795 shares [1][4]. - The new conversion price formula accounts for stock dividends, capital increases, and cash dividends, ensuring that the conversion price reflects changes in the company's equity structure [2][3]. Group 2: Conversion Period - The conversion period for "Weicet Convertible Bonds" is set from October 15, 2025, to April 8, 2031, and the bonds have not yet entered the conversion period [1][5]. Group 3: Communication and Disclosure - The company will disclose any future adjustments to the conversion price in accordance with relevant regulations and will ensure that the rights of convertible bondholders are protected [3][4]. - Investors seeking more information about "Weicet Convertible Bonds" can refer to the company's previously published prospectus on the Shanghai Stock Exchange website [5].

证券代码：301216 证券简称：万凯新材 公告编号：2025-039 债券代码：123247 债券简称：万凯转债 万凯新材料股份有限公司 当公司出现上述股份和/或股东权益变化情况时，将依次进行转股价格调整， 并在深圳证券交易所网站和符合中国证券监督管理委员会规定条件的信息披露 媒体上刊登相关公告，并于公告中载明转股价格调整日、调整办法及暂停转股期 间（如需）。当转股价格调整日为本次可转债持有人转股申请日或之后、转换股 票登记日之前，则该持有人的转股申请按公司调整后的转股价格执行。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 一、转股价格调整依据 经中国证券监督管理委员会《关于同意万凯新材料股份有限公司向不特定对 象发行可转换公司债券注册的批复》（证监许可〔2024〕913 号）同意注册，公 司于 2024 年 8 月 16 日向不特定的对象发行了 27,000,000 张可转换公司债券， 每张面值为人民币 100 元，发行总额为 270,000.00 万元。根据《万凯新材料股 份有限公司向不特定对象发行可转换公司债券募集说明书》（以下简称"募 ...

Group 1 - The company, Kaineng Health Technology Group Co., Ltd., has received approval from the China Securities Regulatory Commission to issue 2.5 million convertible bonds, raising a total of 250 million yuan, with a maturity period of six years from July 20, 2023, to July 19, 2029 [1] - The convertible bond, referred to as "Kaineng Convertible Bond," was listed on August 8, 2023 [1] - The adjustment of the conversion price for the convertible bonds will occur under specific circumstances such as stock dividends, capital increases, or cash dividends, following a defined formula [1][2] Group 2 - The conversion price adjustments will be announced on the Shenzhen Stock Exchange and other media, detailing the adjustment date and method [2] - Historical adjustments to the conversion price have occurred due to cash dividend distributions, with the price changing from 5.67 yuan to 5.62 yuan, and subsequently to 5.52 yuan, 5.47 yuan, and finally to 5.4 yuan [2][3][4] - The latest adjustment, effective from May 30, 2025, will reduce the conversion price from 5.4 yuan to 5.36 yuan due to a cash dividend distribution of 0.4 yuan per 10 shares [4]